BASES PHARMACOCINETIQUES DE L'ANTIBIOTHERAPIE DANS LES INFECTIONS BRONCHOPULMONAIRES BACTERIENNES

Translated title of the contribution: Pharmacokinetics basis for antibiotic therapy in broncho-pulmonary bacterial infections

J. Grosset, R. Bismuth, J. Nguyen

Research output: Contribution to journalArticle

Abstract

Pharmacokinetics is the study of the absorption, distribution and elimination of a drug in the body. Applied to antibiotic therapy, it gives information on the concentrations of antibiotics that reach the bacteria at a given time at their site of multiplication for a given dose and route of administration. The future of an antibiotic within a body is largely related to passive transfer. This can be compared to the dialysis of molecules across a semi-permeable membrane, the passage from one side to the other being a function of the concentration of molecules in the 'upstream' side, the size of the molecules and their own particular transfer speed. The final result is affected by: the partition coefficient itself related to the degree of aqueous and lipid solubility of the molecules; the degree of ionisation of the molecules, non-ionised molecules being the only ones to be transferred; protein binding, as only the unbound fraction is biologically active and capable of diffusing across the membranes; and by the interplay of the combined phenomena of resorption, distribution and elimination. Penicillins and macrolides are the antibiotics of choice in broncho-pulmonary infections. The tetracyclines and the sulfamethoxazole-trimethoprim combination come second. The combination of a β-lactam, an aminoglycoside and/or metronidazole are reserved for the most severe infections. The lung being a particularly well-vascularised organ, the pulmonary concentrations of the antibiotic may equal the serum levels. But the concentration in the bronchial secretions only reaches 55% of the serum levels for clindamycin, 25 to 30% for aminoglycosides, minocycline and bacampicillin, 20% for cephalosporins and doxycycline and less than 10% for ampicillin and erythromycin. Only oleandomycine, spiramycin and trimethoprim are present in concentrations equal to those in the serum.

Original languageFrench
Pages (from-to)195-203
Number of pages9
JournalRevue Francaise des Maladies Respiratoires
Volume10
Issue number3
StatePublished - 1982
Externally publishedYes

Fingerprint

Bacterial Infections
Pharmacokinetics
Anti-Bacterial Agents
Lung
Aminoglycosides
Serum
Spiramycin
Lactams
Tetracyclines
Minocycline
Trimethoprim
Membranes
Clindamycin
Doxycycline
Macrolides
Metronidazole
Sulfamethoxazole Drug Combination Trimethoprim
Erythromycin
Cephalosporins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

BASES PHARMACOCINETIQUES DE L'ANTIBIOTHERAPIE DANS LES INFECTIONS BRONCHOPULMONAIRES BACTERIENNES. / Grosset, J.; Bismuth, R.; Nguyen, J.

In: Revue Francaise des Maladies Respiratoires, Vol. 10, No. 3, 1982, p. 195-203.

Research output: Contribution to journalArticle

@article{bcc2f842dbf5498f9884aeb4997c9b3e,
title = "BASES PHARMACOCINETIQUES DE L'ANTIBIOTHERAPIE DANS LES INFECTIONS BRONCHOPULMONAIRES BACTERIENNES",
abstract = "Pharmacokinetics is the study of the absorption, distribution and elimination of a drug in the body. Applied to antibiotic therapy, it gives information on the concentrations of antibiotics that reach the bacteria at a given time at their site of multiplication for a given dose and route of administration. The future of an antibiotic within a body is largely related to passive transfer. This can be compared to the dialysis of molecules across a semi-permeable membrane, the passage from one side to the other being a function of the concentration of molecules in the 'upstream' side, the size of the molecules and their own particular transfer speed. The final result is affected by: the partition coefficient itself related to the degree of aqueous and lipid solubility of the molecules; the degree of ionisation of the molecules, non-ionised molecules being the only ones to be transferred; protein binding, as only the unbound fraction is biologically active and capable of diffusing across the membranes; and by the interplay of the combined phenomena of resorption, distribution and elimination. Penicillins and macrolides are the antibiotics of choice in broncho-pulmonary infections. The tetracyclines and the sulfamethoxazole-trimethoprim combination come second. The combination of a β-lactam, an aminoglycoside and/or metronidazole are reserved for the most severe infections. The lung being a particularly well-vascularised organ, the pulmonary concentrations of the antibiotic may equal the serum levels. But the concentration in the bronchial secretions only reaches 55{\%} of the serum levels for clindamycin, 25 to 30{\%} for aminoglycosides, minocycline and bacampicillin, 20{\%} for cephalosporins and doxycycline and less than 10{\%} for ampicillin and erythromycin. Only oleandomycine, spiramycin and trimethoprim are present in concentrations equal to those in the serum.",
author = "J. Grosset and R. Bismuth and J. Nguyen",
year = "1982",
language = "French",
volume = "10",
pages = "195--203",
journal = "Revue des Maladies Respiratoires",
issn = "0761-8425",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - BASES PHARMACOCINETIQUES DE L'ANTIBIOTHERAPIE DANS LES INFECTIONS BRONCHOPULMONAIRES BACTERIENNES

AU - Grosset, J.

AU - Bismuth, R.

AU - Nguyen, J.

PY - 1982

Y1 - 1982

N2 - Pharmacokinetics is the study of the absorption, distribution and elimination of a drug in the body. Applied to antibiotic therapy, it gives information on the concentrations of antibiotics that reach the bacteria at a given time at their site of multiplication for a given dose and route of administration. The future of an antibiotic within a body is largely related to passive transfer. This can be compared to the dialysis of molecules across a semi-permeable membrane, the passage from one side to the other being a function of the concentration of molecules in the 'upstream' side, the size of the molecules and their own particular transfer speed. The final result is affected by: the partition coefficient itself related to the degree of aqueous and lipid solubility of the molecules; the degree of ionisation of the molecules, non-ionised molecules being the only ones to be transferred; protein binding, as only the unbound fraction is biologically active and capable of diffusing across the membranes; and by the interplay of the combined phenomena of resorption, distribution and elimination. Penicillins and macrolides are the antibiotics of choice in broncho-pulmonary infections. The tetracyclines and the sulfamethoxazole-trimethoprim combination come second. The combination of a β-lactam, an aminoglycoside and/or metronidazole are reserved for the most severe infections. The lung being a particularly well-vascularised organ, the pulmonary concentrations of the antibiotic may equal the serum levels. But the concentration in the bronchial secretions only reaches 55% of the serum levels for clindamycin, 25 to 30% for aminoglycosides, minocycline and bacampicillin, 20% for cephalosporins and doxycycline and less than 10% for ampicillin and erythromycin. Only oleandomycine, spiramycin and trimethoprim are present in concentrations equal to those in the serum.

AB - Pharmacokinetics is the study of the absorption, distribution and elimination of a drug in the body. Applied to antibiotic therapy, it gives information on the concentrations of antibiotics that reach the bacteria at a given time at their site of multiplication for a given dose and route of administration. The future of an antibiotic within a body is largely related to passive transfer. This can be compared to the dialysis of molecules across a semi-permeable membrane, the passage from one side to the other being a function of the concentration of molecules in the 'upstream' side, the size of the molecules and their own particular transfer speed. The final result is affected by: the partition coefficient itself related to the degree of aqueous and lipid solubility of the molecules; the degree of ionisation of the molecules, non-ionised molecules being the only ones to be transferred; protein binding, as only the unbound fraction is biologically active and capable of diffusing across the membranes; and by the interplay of the combined phenomena of resorption, distribution and elimination. Penicillins and macrolides are the antibiotics of choice in broncho-pulmonary infections. The tetracyclines and the sulfamethoxazole-trimethoprim combination come second. The combination of a β-lactam, an aminoglycoside and/or metronidazole are reserved for the most severe infections. The lung being a particularly well-vascularised organ, the pulmonary concentrations of the antibiotic may equal the serum levels. But the concentration in the bronchial secretions only reaches 55% of the serum levels for clindamycin, 25 to 30% for aminoglycosides, minocycline and bacampicillin, 20% for cephalosporins and doxycycline and less than 10% for ampicillin and erythromycin. Only oleandomycine, spiramycin and trimethoprim are present in concentrations equal to those in the serum.

UR - http://www.scopus.com/inward/record.url?scp=0020320133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020320133&partnerID=8YFLogxK

M3 - Article

C2 - 7111829

AN - SCOPUS:0020320133

VL - 10

SP - 195

EP - 203

JO - Revue des Maladies Respiratoires

JF - Revue des Maladies Respiratoires

SN - 0761-8425

IS - 3

ER -